Atlas Trials

Ascendis Pharma Bone Diseases A/S

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ascendis Pharma Bone Diseases A/S

RecordFirmDate
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism (NCT07081997)Ascendis Pharma Bone Diseases A/S2026-05-07

Track Ascendis Pharma Bone Diseases A/S automatically

Every clearance here is in the API, with alerts when new ones post.